Bookmark
Forward
Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist.
University of California, San Francisco, USA.
Cancer practice 1997 Sep-OctSizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Y F Hui, R J Ignoffo. Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist. Cancer practice. 1997 Sep-Oct;5(5):324-8
Mesh Tags
Substances
PMID: 9341357
View Full Text
